TickerFacts.

Bon Natural Life Ltd (BON): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

-$535.6K
Year ended 2025-09-30
$6.89M2022-09-30: $6.82M2023-09-30: $6.89M2024-09-30: $2.98M2025-09-30: -$535.6K-$535.6K
2022-09-30 EBITDA (USD) 2025-09-30
Period endedEBITDAChange YoYSource filing
2025-09-30-$535.6Kn/m2026-01-23, From 2024-10-01
2024-09-30$2.98M-56.7%2026-01-23, From 2023-10-01
2023-09-30$6.89M+1.0%2026-01-23, From 2022-10-01
2022-09-30$6.82Mn/a2025-04-16, From 2021-10-01

EBITDA at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Bon Natural Life Ltd (BON)2025-09-30-$535.6Kn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31-$2.13Mn/m
Cyanotech Corp (CYAN)2025-03-31-$1.03Mn/m
Synergy CHC Corp. (SNYRQ)2025-12-31-$8.33Mn/m
C21 Investments Inc. (CWLXF)2026-03-31$4.06M+35.8%
Leef Brands Inc. (LEEEF)2025-12-31-$6.33Mn/m
Functional Brands Inc. (MEHA)2025-12-31-$1.38Mn/m
Fitlife Brands, Inc. (FTLF)2025-12-31$10.48M-20.8%
Mannatech Inc (MTEX)2025-12-31$666.0K-77.5%

Compare BON, CHUC, CYAN, SNYRQ side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗